The Medical University of South Carolina is accusing a drug manufacturing giant of ripping off an MUSC scientist's intellectual property.
The Post and Courier of Charleston reports (http://bit.ly/JHdV9U ) that MUSC's Foundation for Research Development and Charleston Medical Therapeutics sued Delaware-based AstraZeneca Pharmaceuticals in December for patent infringement.
The federal Food and Drug Administration approved the use of cholesterol drug Crestor to treat vascular inflammation in 2010.
The lawsuit says the FDA approval infringes on patents first obtained by MUSC's Dr. Inderjit Singh in 2003.
MUSC also says AstraZeneca shouldn't be allowed to market and sell Crestor as a medication to treat patients with vascular inflammation without a history or risk of cardiovascular disease or stroke.
A spokesman for AstraZeneca says the drug maker will defend itself against the allegations.